739 related articles for article (PubMed ID: 9569187)
1. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Lin L; van Pelt J; Hess G; Vermylen J; Yap SH
Thromb Haemost; 1997 May; 77(5):868-72. PubMed ID: 9184394
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
Hitzler WE; Runkel S
Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
[TBL] [Abstract][Full Text] [Related]
5. GBV-C/HGV infection in end-stage renal disease: a serological and virological survey.
Fabrizi F; Lunghi G; Pozzi C; Colzani S; Tentori F; Del Vecchio L; Corti M; Pagano A; Locatelli F
J Nephrol; 2000; 13(1):68-74. PubMed ID: 10720218
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
[TBL] [Abstract][Full Text] [Related]
8. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
Sauleda S; Reesink HJ; Esteban JI; Hess G; Esteban R; Guardia J
J Med Virol; 1999 Sep; 59(1):45-51. PubMed ID: 10440807
[TBL] [Abstract][Full Text] [Related]
9. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
[TBL] [Abstract][Full Text] [Related]
10. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
[TBL] [Abstract][Full Text] [Related]
11. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis G virus (HGV) infection in an endemic area of hepatitis C virus (HCV) infection.
Kitano M; Sakaguchi K; Miyashita M; Mouri H; Senoh T; Nishimura M; Ohta T; Fujio K; Shimomura H; Tsuji T
Hepatogastroenterology; 2000; 47(35):1340-2. PubMed ID: 11100347
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
[TBL] [Abstract][Full Text] [Related]
16. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
Kaya S; Cicioğlu Aridoğan B; Demirci M
Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
[TBL] [Abstract][Full Text] [Related]
17. [A cross-sectional study on HGV infection in a rural population].
Ling B; Zhuang H; Cui Y
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):359-62. PubMed ID: 10923441
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs.
Tàssies D; Magallón M; Quintana M; Fernández-Urgellés RP; Rodriguez-Pinto C; Tusell J; Altisent C; Reverter JC; Mazzara R; Ordinas A; Monteagudo J
Haematologica; 1999 Oct; 84(10):930-6. PubMed ID: 10509042
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
